FAQ/Help |
Calendar |
Search |
Today's Posts |
02-11-2014, 11:50 PM | #2 | ||
|
|||
Member
|
Lazy science, to anyone still wondering why ldopa is king after 40 years it's due to "products" of little value like this one.
Just what the world of pd needs, another patch. Neil. |
||
Reply With Quote |
|
|
Similar Threads | ||||
Thread | Forum | |||
NeuroDerm Announces Presentation of ND0612 Phase 1 and Phase 2 Results at the 2013 In | Parkinson's Disease | |||
NeuroDerm Announces Positive Results of a Phase II Study of ND0611 Dermal Patch in Pa | Parkinson's Disease | |||
Biotie Announces Start of Phase 2b Trial of SYN115 in Parkinson's Disease | Parkinson's Disease | |||
Neurologix Announces Successful Phase 2 Trial of Gene Therapy for Parkinson's Disease | Parkinson's Disease | |||
Ceregene announces positive phase 1 results ... | Parkinson's Disease |